Trial Profile
A double-blind, randomized study comparing intramuscular olanzapine depot to oral olanzapine and low-dose depot in the maintenance therapy of patients with schizophrenia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Aug 2011
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary)
- Indications Schizophrenia
- Focus Registrational; Therapeutic Use
- 30 Sep 2008 Added ref 9093553.
- 23 Jun 2008 Results presented at the First Annual Schizophrenia International Research Society Conference in June.
- 30 Jan 2007 Status changed from recruiting.